BIND Therapeutics To Report Third Quarter 2014 Financial Results On November 6, 2014

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced it will report third quarter 2014 financial results on Thursday, November 6, 2014. BIND’s management team will host a conference call and audio webcast on Thursday, November 6, 2014 at 8:30 a.m. Eastern Time to discuss the quarterly results and recent business developments.

Help employers find you! Check out all the jobs and post your resume.